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in the other two cases. Patients were found symptoms-free at 
follow-up. One patient underwent a second stent placement.
Conclusions: The present method results a safe alternative 
endoscopic procedure in very selected patients when surgery is not 
indicated.
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Background and aim: Gastroenteropancreatic neuroendocrine 
tumors (GEP-NETs) are nosological entities, whose incidence has 
dramatically increased during the last decades.
Endoscopic ultrasonography (EUS), associated to FNA and harmonic 
contrast-enhancement (CH-EUS), has been reported to be extremely 
useful for the diagnosis and the staging.
The objective of this study is to evaluate the accuracy of EUS in the 
diagnosis and the staging of GEP-NETs.
Material and methods: From January 2010 to September 2015, all 
NET’s patients referred for EUS in our center were enrolled in this 
study.
According to the localization of the tumor, the patients also 
underwent laboratory tests and imaging techniques such as CT, MRI, 
SRS Octreoscan or DOTATOC. EUS procedures were performed using 
radial or linear echoendoscopes Pentax EG-3670URK–EG-3870UTK 
(Pentax Hamburg, Germany) with a Hitachi – Aloka Avius processor 
(Hitachi, Hamburg, Germany).
FNA procedures were performed with 25G FNA biopsy needles 
(EchoTip, Wilson-Cook Medical Inc, Winston-Salem, NC) and 
SonoVue (Bracco, Milano, Italy) was used for CH-EUS.
Results: 26 patients were enrolled in the study (17 m, 9 f) with 
median age of 56.9 years (range 10 - 87).
NET’s were located in upper GI tract in 9 patients (6 stomach, 3 
duodenum), in the rectum in 7 patients and in the pancreas in 10 
patients.
In the patients with upper GI NET’s, found at bioptic sampling, EUS 
confirmed endoscopical resection in 1 patient; surgical resection 
in 4 patients because of an invasion of the deeper layers; medical 
treatment in 4 patient with advanced disease.
In the patients with rectal NET’s, found at bioptic sampling in 
colonoscopy, EUS permitted to choose the mucosectomy in 6 
patients, and in 1 case surgical approach.
In pancreatic localization, CH-EUS showed a fast enhancement 
with a homogeneous pattern lesion in 3 patients with recurrent 
hypoglycemias. FNA confirmed the diagnosis of insulinoma in all 
cases.
CT suspected a pancreatic NET in the other 7 patients, EUS+FNA 
confirmed the presence of neuroendocrine tumor. FNA was 
performed with a mean of 2.0 passages per patient.
Three patients underwent surgery, while the others underwent 
medical therapy for the advanced disease.
Neither major or minor complications showed up during or after the 
procedures.
Conclusions: This study highlights the diagnostic accuracy, safety of 
EUS in the evaluation and management of GEP-NETs. In particular, 
EUS was necessary to define whether the lesion could be managed 
endoscopically or surgically.
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Background and aim: Fifteen percent of patients with suspected 
pancreatobiliary malignancy that undergo surgery without 
a cytological assessment have a benign lesion. Cytological or 
histological diagnosis of pancreatobiliary malignancies before 
surgery is desirable in order to avoid unnecessary interventions.
We conducted a study in order to assess whether the combined use 
of biliary brushing and endoscopic ultrasound-guided fine needle 
aspiration (EUS--FNA) has greater accuracy than the individual 
procedures in diagnosing pancreatobiliary malignancies.
Material and methods: Study was conducted at the Gastroenterology 
Unit of Academic Hospital “S. M. della Misericordia”, Udine, Italy. 
Twenty five patients with probable pancreatobiliary malignancy 
were subjected both to biliary brushing and EUS-FNA and collected 
material was sent for cytological analysis. The results of cytology 
were compared to the results of histology from surgical specimen.
Results: Histology of surgical specimen confirmed the diagnosis 
of pancreatobiliary malignancy in 24 of 25 patients, benign lesion 
caused by chronic pancreatitis was identified in one patient. 
Cytology from biliary brushing provided a correct diagnosis in 
9 patients, with diagnostic accuracy of 36%. For the remaining 16 
patients (54%), cytological diagnoses were as follows: indeterminate 
because of poor quantity or quality of the specimen in 15 patients, 
negative in one case (1 false negative). EUS-FNA provided a correct 
diagnosis in 18 patients with diagnostic accuracy of 72%, including 
the patient with a benign lesion. In 7 patients (28%) EUS-FNA didn’t 
provide any result because of the poor quality of the specimen. The 
combined diagnostic accuracy of both methods was 80% as they 
together provided a correct diagnosis in 20 patients. The additional 
diagnostic gain derived from the joint use of biliary brushing and 
EUS-FNA was +44% compared to biliary brushing alone and +8%. 
cases compared to EUS-FNA alone.
Conclusions: The combined use of the EUS-FNA and biliary 
brushing results in increased accuracy of cytological diagnosing 
in pancreatobiliary malignancies. The biliary brushing as an 
addition to EUS-FNA should be considered in patients undergoing 
the endoscopic retrograde cholangiopancreatography (ERCP) in 
therapeutic purposes.
